RecruitingPhase 1NCT07163403

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

Studying Hereditary nonpolyposis colon cancer

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundacion Clinic per a la Recerca Biomédica
Intervention
Autologous Tolerogenic Dendritic cells(biological)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20252028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07163403 on ClinicalTrials.gov

Other trials for Hereditary nonpolyposis colon cancer

Additional recruiting or active studies for the same condition.

See all trials for Hereditary nonpolyposis colon cancer

← Back to all trials